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Abstract  
Background Evaluations of complex interventions compared to usual care provided in palliative care 
are increasing. Not describing usual care may affect the interpretation of an intervention’s 
effectiveness, yet how it can be described remains unclear.  
Aim To demonstrate the feasibility of using multi-methods to describe usual care provided in 
randomised controlled trials (RCT) of complex interventions; demonstrated within a feasibility 
cluster RCT. 
Design Multi-method approach comprising usual care questionnaires, baseline case note review and 
focus groups with ward staff completed at study end. Thematic analysis of qualitative data, 
descriptive statistics of quantitative data, followed with methodological triangulation to appraise 
approach in relation to study aim. 
Setting/participants Four general medical wards chosen from UK hospitals. Purposive sampling of 
healthcare professionals for usual care questionnaires, and focus groups. Review of 20 patients’ 
notes from each ward who died during admission or within 100 days of discharge. 
Results 23 usual care questionnaires at baseline, two focus groups comprising 20 healthcare 
professionals and 80 case note reviews. Triangulation of findings resulted in understanding the usual 
care provided to the targeted population in terms of context, structures, processes, and outcomes 
for patients, families, and healthcare professionals. usual care was described, highlighting (i) 
similarities and embedded practices, (ii) heterogeneity, and (iii) subtle changes in care during the 
trial within and across sites. 
Conclusions We provide a feasible approach to defining usual care that can be practically adopted in 
different settings. Understanding usual care enhances the reliability of tested complex interventions 
and informs research and policy priorities. 
Keywords Randomised control trials, usual care, comparison, control, treatment, as usual, multi-
method, mixed-method, complex interventions  
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Key statements 
What is already known about the topic? 
 Usual care provided to patients is rarely described in detail in randomised controlled trials 
(RCTs) of a complex intervention in palliative care.  
 To interpret the effectiveness of interventions tested within RCTs, the care provided in the 
comparison arm must be described.  
 Approaches including the use of open-ended questions and observations have been used in 
trials to understand care provided but lack convergent validity. 
What this paper adds 
 Usual care provided in an RCT was characterised using a multi-method approach at different 
time-points and from different professional perspectives. 
 Similarities and variations in the care provided to patients within and across study sites and 
over time were identified refuting the assumption that all control participants received the 
same usual care. 
 This paper provides a method for the classification of the usual care that should be 
embedded within RCTs of complex interventions.  
Implications for practice, theory or policy 
 Assumptions made about the usual care delivered to patients during intervention 
development may not always remain valid at the testing stage.  
 Characterising usual care ensures that interpretation of findings of the effectiveness of the 
tested intervention is more valid. 
 To avoid incorrect interpretations of complex interventions in palliative care, usual care is 
best characterised using a multi-method approach embedded within the design of RCTs. 
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Introduction 
Towards the end of life, patients and their families, have complex needs. In recent years, palliative 
care interventions have been developed to improve care. 1, 2 While essential in all aspects of care, 
person-centred care, promoting autonomy and choice are vital in palliative care provision.3 
However, palliative care practices and end-of-life care policies vary across care settings, and 
different patient populations. 4,5 Complex interventions have been evaluated using randomised 
controlled trials (RCTs) where the tested intervention was compared to ‘standard ’ or ‘usual’ care. 6, 7 
Usual care is the care the targeted patient population would be expected to receive as part of the 
normal practice, and within RCTs refers to the care the participants who are not receiving the tested 
intervention receive.8 Usual care should reflect locally adapted practices. Care may also vary at 
different time-points during a trial.  Whilst researchers have paid attention to clearly defining the 
interventions within trials 9, scant attention has been paid to describing the characteristics of care 
provided to controls, and in some instances patients in the test arm in the absence of the 
intervention. This concern is amplified by international reporting guidelines for RCTs emphasising 
the importance of providing a detailed explanation of the comparison.8, 10   
Not detailing the care in comparison, presumes all control participants receive a similar standard of 
care, within and across sites, and that usual care practices remain unchanged during the trial.11 
Taking part in a research study may influence the care provided within the control arm of an RCT. 12 
If the usual care is incorporating the latest evidence, it may also resemble the tested complex 
intervention.13 Without this information, interpreting the effectiveness of the intervention is 
challenging.14 Providing clear descriptions of the intervention and usual care is critical for 
understanding the fidelity of implementation and delivery of an intervention tested across settings.11 
Defining usual care may also provide valuable information for further development of the complex 
intervention and inform its scalability to other settings, by benchmarking and identifying areas that 
could be improved to achieve a better quality of care.15 
Attempts have been made to describe usual care including open-ended questionnaires to gauge 
health professionals’ understandings of care provided to patients. 9, 14, 16 Open-ended questions offer 
a practical approach to understand ‘treatment-as-usual’, yet the use of a single self-report method 
limits understanding to practitioners’ views. Incorporating  multiple data sources and triangulation 
across them enable exploration of different constructs of usual care. 17, 18 Multi-method approaches 
such as direct clinical observations can be time and resource-intensive 19. Indirect methods, including 
using routine data may be appropriate, particularly when used in multi-centre, large-scale trials. 
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We aimed to demonstrate how a multi-methods approach can be adopted to describe the usual care 
provided in RCTs of complex interventions. The usual care provided prior to the implementation of 
the complex intervention for the chosen intervention sites, and the care provided in the control 
arms throughout the trial, is described within the feasibility cluster RCT of the AMBER Care bundle.20 
This is a complex intervention aimed at providing better care to patients whose situations are 
‘clinically uncertain’, with an irreversible, deteriorating condition, and at risk of dying during their 
hospital admission. 20-23   
Methods  
Design  
Prospective, longitudinal, multi-method study within a parallel, feasibility cluster RCT of a complex 
intervention (ISRCTN36040085).5, 20, 24, 25 Data were collected between June 2017 and August 2018.  
Setting  
Four district general hospitals26 in England were randomised to the intervention and control arms of 
the trial (Table 1). Within each of these four hospitals, one general medical ward was purposefully 
chosen as the study ward based on the number of deaths. The selection process of study wards at 
each study site is detailed elsewhere.20 As the usual care questionnaires and case notes reviews 
were conducted at baseline, prior to the implementation of the intervention, the baseline data from 
the two intervention study wards were also included for the description of usual care. 
Data collection 
The AMBER care bundle focuses on managing clinical uncertainty and improving communication 
within the multidisciplinary teams and with patients and families27. Exploration of usual care needed 
to enable comparison with this complex intervention by understanding the constructs of managing 
clinical uncertainty in current practice. The literature on existing methods of assessing usual care,9, 11 
process evaluations15, 28, 29 and integrative models of relations between the quality of care and health 
outcomes30 was reviewed. As a result, we identified important aspects that were required to provide 
a clear understanding of the usual care provided across study sites. This included the context, 
healthcare professionals delivering the care, structures and processes in the wards and hospitals, 
and relevant anticipated outcomes of care for the patients, and their families. We chose methods 
which can be woven into the design of the cluster RCT, and the clinical context within the constraints 
of limited resources. We used the following data collection methods: usual care questionnaires, 
focus groups, and case note reviews. 
Usual care questionnaires 
We used a self-report questionnaire to explore usual care with healthcare professionals. The 
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questionnaire was administered in the control wards and the intervention wards at baseline only. We 
developed a study-specific questionnaire to document usual care across the whole trial (See 
Supplementary File 1). This enabled exploration of usual care aligned to key constructs of our 
intervention 9 and drawing on studies to inform the content and format. The questionnaire included 
23 questions, mainly open-ended questions. The questions explored the structures, processes, and 
outcomes of care15, including initial care planning, communication with families, recognising dying and 
clinical uncertainty, referrals and discharge procedures. We piloted the questionnaire at two wards of 
a London teaching hospital. The pilot explored the questionnaire content and format with questions 
subsequently re-worded for clarity. Pilot data were not included in the main data. 
We purposefully sampled healthcare professionals based on their profession and seniority to aim to 
recruit five participants from each site with representation from across the multi-disciplinary team 
(e.g. Medical consultant, Ward sister/manager, Junior doctor, Staff nurse, Healthcare assistant). 
Potential participants were identified and approached by the local research nurses working at the 
study sites.  
Focus groups  
Focus groups were undertaken in each site with clinicians at after completion of data collection for 
the main trial outcome. The focus groups intended to explore the experiences of healthcare 
professionals in caring for, and communicating with, patients whose situations were clinically 
uncertain, and their families. We explored communicating with patients and their families about 
clinically uncertain situations, teamwork, and practices for enhancing communication of the 
healthcare professionals who worked on the control sites. The topic guide was informed by studies 
examining the intervention acceptability and use.22, 23 Eligible participants were identified and 
approached by the research nurses at each study sites, and a poster advertising the focus group for 
staff displayed on each ward. To enable participation, the focus groups were held at lunchtimes in 
meeting rooms on the study wards. Focus groups were led by either one of the researchers: JK (male) 
and CE (female); both senior researchers experienced in complex interventions, palliative care and 
qualitative research. Field notes were taken (EY and HJ). Focus groups were audio-recorded and 
transcribed verbatim. 
Case note reviews 
The case note reviews21  were conducted by a palliative care clinical nurse specialist at baseline in all 
four sites. The nurse specialist was the facilitator for the AMBER care bundle intervention. Case note 
reviews enabled exploration of more objective data on usual care to complement the self-report 
questionnaire data which may be subject to social desirability bias.31, 32 The note reviews comprised 
10 patients who died during admission and 10 who died within 100 days of discharge. Each case note 
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was randomly selected from the deaths during or after the admission. This intended to include case 
notes for individuals with a clinically uncertain prognosis during the admission. Case notes of the 
deceased patients were only accessed by hospital staff with clinical responsibility for the care in the 
ward. De-identified anonymous information was used as research data and shared with the research 
team. This method of case note review was part of the AMBER care bundle ‘benchmarking’ process to 
understand usual care at baseline and monitor change overtime.  
Analysis  
Qualitative data from the usual care questionnaires and focus groups were analysed separately. For 
the analysis of the focus group data, thematic analysis informed by the Framework approach was 
conducted, to inductively code, organise, and identify emerging themes.33 The first steps of the coding 
and analysis were performed by EY (female), who is a research assistant with experience in mixed-
methods. To enhance analytical rigour the researchers (EY, JK, HJ) reviewed coding and completeness 
of the framework. Where coding differed, issues were reconsidered by HJ, JK, and EY until a consensus 
was achieved. 34 Unusual or non-confirmatory views were examined and unwarranted claims about 
patterns were avoided. Excerpts were used to illustrate themes.  
Usual care questionnaire data were analysed by EY adopting a directed content analysis approach 
prior to triangulation.35, 36 Coding was deductive in terms of pre-determined categories of structures, 
processes, and outcomes, similarities, variations, and changes over time. This methodology allows 
flexibility for survey designs which include quantitative, open and closed-ended questions.36 
Identifiable information was removed preserving confidentiality for both the focus groups and the 
usual care questionnaires. Qualitative data from the focus groups were managed in NVivo 1137 and 
data from the usual care questionnaires were managed in SPSS. 38 
We used descriptive statistics for the numerical data in the usual care questionnaire and case note 
review data analysed using SPSS38.  
The findings from three data sources were triangulated at the interpretation stage looking for 
correspondence (complementary information on the same issue), convergence (findings from 
different data sources agreeing), divergence (findings from different data sources contradicting each 
other), and silences (a theme or a finding arising from one data source and not from the others) after 
all data from different sources had been analysed separately.39-41 The integration of findings from 
more than one data sources with a different methodology to address the same phenomenon is known 
as “data triangulation”.39, 41 We believed that inter-method discrepancies may lead to a better 
understanding of usual care and in doing so highlight the areas for potential improvement. We also 
considered silences to be a possibility since while using a multi-method approach, different methods 
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will have varying strengths about contributing to the description of the usual care. 
 
Research governance and ethical approval  
Ethical approval was obtained from the National Research Ethics Committee - Camden and King’s 
Cross (20.12.2016, REC Reference: 16/LO/2010) and Health Research Authority (25.01.2017). 
Research governance approvals were obtained from participating hospitals.  
Results 
Usual care questionnaires 
Twenty-three healthcare professionals completed the usual care questionnaire at baseline (Table 2). 
We were able to purposively sample healthcare professionals across a range of professional groups 
and seniority. We initially aimed to recruit and obtain five questionnaires from each ward, however, 
one of the study wards was significantly larger than the others, as it has just been recently conjoined 
to an adjacent ward. Hence, we collected data from eight instead of five healthcare professionals to 
have better coverage of the care provided in this ward. Although initially, the usual care 
questionnaires were planned to be repeated at consecutive time-points, this was not feasible within 
the short data collection period. Collecting data at baseline from a range of healthcare professionals 
was feasible. Completeness of the usual care questionnaires was high with a median of 97.6% (range: 
58.3% - 100%) of the questionnaire completed per participant. The questions within the usual care 
questionnaire were deemed as completed if the participant provided an answer, or stated that they 
did not know the answer. The usual care questionnaire took approximately 15 minutes to complete.  
Focus groups  
Two focus groups were conducted with healthcare professionals at two control site wards, attended 
by 20 healthcare staff (n=9 and n =11, respectively) (Table 3). Participants represented the multi-
disciplinary team, but there was no representation from nursing in control-site 2 with staff shortages 
precluding attendance. 
Case note reviews 
80 case note reviews were completed (Table 4). Most of the decedents were aged over 71 years (55%) 
and had a primary diagnosis of cancer or respiratory disease.  
Describing usual care across the study sites 
By triangulating data from the focus groups, usual care questionnaires, and case note reviews on the 
construct of usual care, we were able to define and classify usual care for patients whose situations 
were clinically uncertain. The classification comprised: of: (i) similarities and embedded practices; (ii) 
heterogeneity within, and across study sites, and (iii) subtle changes in the control arm during the 
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study (Table 5). Within this trial’s study sites, we observed similarities across the domains of admission 
and current care planning, communication with the patient and famility, escalation decisions, 
recognition of the clinical uncertainty, and the meotional support provided to the staff members. 
Whereas, heteregenetiy within and across the study sites were observed for documentation of 
deterioration and specialist involvement, advance care planning, decision-making processes and 
communication between ward staff, and competence and confidence of the ward staff in 
communication. Finally, subtle changes in the usual care were observed at the control sites; 
specifically relating to the changing attitudes towards referral practices to the pallitiave care team.  
Discussion  
We demonstrated how a multi-method approach can successfully be adopted within the financial 
and time constraints of a trial to describe comprehensively the usual care provided to the patient 
population targeted by the complex intervention. While widely used statements such as CONSORT10 
and TIDieR8 call for a description of the care provided in the control group, no guidance is provided 
for how this information should be obtained, specifically for RCTs of complex, common in palliative 
and end of life care.9 Building on from the literature and using a multi-method approach, we 
identified embedded practices and variability in care provided to patients across four sites within a 
multi-centre RCT, highlighting the importance of reliably collecting information on the quality of 
care, rather than assuming a similar standard of care. We also identified subtle changes in clinical 
practices of staff in the control arm from baseline onwards. While in the exemplified trial, changes in 
the control arm were small, in larger trials, understanding and monitoring for potential changes in 
the usual care practices hold an imperative value for the complex intervention’s development and 
implementation.  
Within the context of this trial,20 where the complex intervention was designed to serve patients 
with a terminal diagnosis, and their families, quality of care and treatments can be highly variable.4 
Complex interventions tend to be subtlety modified during local adaptation, adding on to the 
heterogeneity of the usual care in clinical practice.28 To optimise patient and family outcomes, care 
is expected to be personalised, where the patients and family members are seen as equal partners in 
decision making regarding care.42 Aspects of person-centred care, for example coordinating and 
integrating care, ensuring continuity of care and multidisciplinary working 42, rely on having 
embedded clinical structures and processes. This requires staff across different professional groups 
to actively engage with them as part of their usual practice. Understanding contextual aspects of the 
usual care across sites, variability amongst healthcare professionals, and triangulation with data 
from patients’ notes, enables researchers and intervention developers to map aspects of care 
expected to be uniform, and thsoe expected to be heterogeneous. This knowledge assists in 
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identifiying the linkages between the mechanisms of a complex intervention and the intended 
outcomes, compared to the usual care within an RCT. As RCTs are accepted as providing the highest 
level of evidence,43 defining the usual care by incorporating a multi-method approach within RCTs 
should represent a sensible methodological addition to this study design. This maximises the utility 
of findings on the processes as to how the intervention works to deliver the intended outcomes, and 
the requirements for use, compared to usual care. 
Historically, ensuring high-quality care to individuals involved standardising the usual care, and 
having interventions in place to deliver treatments and care, with little flexibility. However, there is a 
danger that these interventions can easily turn into ‘tick-box’ exercises, and in some instances, when 
not combined with adequate evaluation may lead to harm instead of benefit to patients.44, 45 
Increasing evidence points in the direction of a healthcare model which involves interpretation of 
research evidence for the delivery of person-centred care in clinical practice.46, 47 Describing the 
usual care within RCTs intends to illuminate understanding on the context by exploring differences 
between settngs and levels of care in clinical contexts (e.g. micro, macro, and chrono-systems)48. 
Undesrtanding context is essential for embedding evidence-based change in clinical care to enhance 
clinical effectiveness for patients.   
Our findings highlight important variability in the manner ‘usual ’ care was provided within, and 
across study sites, having implications for both the way findings from similar RCTs of complex 
interventions are interpreted in terms of the comparator, and the requirment for successful 
implementation.11 While findings converged on prioritising and informing patients and families 
about their clinical situation, we identified variance in healthcare professionals’ perceptions of their 
competence in communicating with patients and families when prognosis was uncertain, 
involvement of each ward staff member in clinical decision-making, and effective communication 
between ward staff regarding patient and family’s knowledge. These findings highlight the lack of 
similar usual care in the control arm. Some control participants may have been receiving usual care 
that was different compared to the intervention, others may have received care similar to patients in 
the intervention arm. Heterogeneity of care received in the control arm, if not successfully contrived 
with randomisation, may reduce the chance of detecting potential effects of the tested intervention. 
Not having a clear understanding of the usual care and how it compares to the complex intervention 
could lead to overinterpretation of its benefits or deprive patients, whose needs remain unmet, of a 
potentially beneficial intervention. 
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Strengths and limitations  
The use of a multi-method approach enabled detailed exploration of the healthcare professionals’ 
perceptions on care provision, enhanced through case note reviews to provide a deeper exploration 
of specific clinical activities. Data triangulation enabled convergence and divergence across the data 
sets.  
When considered in isolation, the findings from the usual care questionnaires and focus groups may 
be interpreted with caution due to subjectivity. Triangulation with the case note reviews overcome 
this concern. 
The data collection methods for characterising usual care were easy to implement within the context 
of a feasibility multi-centre, cluster RCT, with relatively limited resources. Capturing the important 
aspects of the care within the specified context is valuable, yet there were no available 
questionnaires which could be adapted for this study.9 Hence, we developed the usual care 
questionnaire specifically for this study. While being piloted and proven to be successful in aiding in 
describing the usual care, this tool was not validated.  
We were not able to capture healthcare professionals approached and those who refused to take 
part in the focus groups, or the usual care questionnaire, hence opinions of those who participated 
in the study might differ from those who did not.  
We are mindful of the absence of nursing representation in one of the focus groups. This limits our 
findings’  transferability to other care settings. We wanted to purposefully include the nurses in the 
focus groups, proportionate to their integral role in patients’ care. Although, several nurses 
expressed interest, and confirmed their availability beforehand, on the day of the focus group no 
nurses were able to attend, due to urgent clinical commitments. This highlights the issues faced 
while conducting research in a real-life context. In future, studies should aim to improve nursing and 
allied-health professional representation by considering additional flexibility and resources in the 
study design to accommodate the unpredictable nature of clinical work.   
We were not able to conduct direct observations of care due to logistical constraints. Direct 
observation of clinical practice might not always be feasible or ethically acceptable for vulnerable 
populations. However, studies should consider incorporating non-participant observation of care 
delivery to gain a better understanding of usual care, by cross-validating the quality of structure and 
process of care in RCTs of complex interventions.15   
Case note reviews were completed by only one clinical nurse specialist. Having a single person 
responsible for data extraction might introduce rater bias. Where possible, a review of patients’ 
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notes should be carried out by two independent researchers, and report corresponding inter-rater 
reliability. 
Conclusions  
We have shown it is feasible and advantageous to use a multi-method approach to explore usual 
care in RCTs of complex interventions for patients nearing the end of life. We have highlighted 
embedded practices and knowledge, and variability in the usual care depending on healthcare 
professionals’ skills, patient disease groups and contextual factors. This study makes a 
methodological contribution to the research field by providing a practical and feasible approach for 
describing usual care. Whilst there has been a growth in the number of studies that have evaluated 
complex interventions, to date, there has been a lack of agreement on how usual care can be 
defined. We successfully addressed this concern. To optimise the design of RCTs and improve 
evidence-based practice, future studies should adopt and develop the proposed multi-method 
approach in different settings. Within the context of limited funding opportunities for experimental 
studies, researchers conducting RCTs of complex interventions should aim to fully understand, and 
provide a definition of, the usual care. This would provide greater confidence in the study findings. 
Understanding usual care can strengthen the reliability of complex interventions tested in RCTs and 
accordingly set research funding and policy priorities. 
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TABLE 1 Study sites 
Study Arm   Cluster  Specialty Number 
of beds  
End of life care plan  Care Quality Commission rating  
Control-Site-1 1 general 
medical 
ward 
 rheumatology 
 endocrinology 
27  Last days of Life Care Agreement Requires improvement  
Control-Site-2 1 general 
medical 
ward  
 general medicine 
 haematology 
 diabetic 
medicine 
 geriatric 
medicine 
32  Last days of Life Care Agreement 
 The Recognising Dying Assessment and the 
Individual Care Plan 
Good 
Intervention-
Site-1 
11 general 
medical 
ward*  
 care of the 
elderly 
36  End of life care plan  Requires improvement  
Intervention-
Site-2 
1 general 
medical 
ward 
 respiratory  
 endocrinology  
30  Individualised care plan for dying patients Good 
*Two separate wards were recently conjoined to become one ward shotly before the data collection.
16   
 
TABLE 2 Professions who completed the usual care questionnaire 
Study Arm Control Intervention 
Study Site  Control  
Site-1 
Control 
Site-2 
Intervention 
Site-1 
Intervention-
Site-2 
Profession  (N) 
  Consultant 
  Ward sister/manager 
  Junior doctor 
  Staff nurse 
  Healthcare assistant 
  Physician Associate  
5 
1 
1 
1 
1 
1 
0 
5 
1 
1 
1 
1 
1 
0 
8* 
2 
2 
2 
0 
1 
1 
5 
1 
1 
1 
1 
1 
0 
*Two separate wards were recently conjoined to become one ward shotly before the data collection.
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TABLE 3 Focus group participant characteristics  
Study site Specialties in involved Professionals involved (Gender) Duration  
Control-
Site-1 
(N=9) 
Haematology 
Diabetes 
Junior doctor (M*) 
Occupational Therapist (F**) 
Ward sister (F) 
Research nurse (F) 
Research practitioner (F) 
Matron of research (F) 
Staff nurse (F) 
Palliative care consultant (M) 
Junior doctor (F) 
60 minutes 
Control-
Site-2 
(N=11) 
Rheumatology 
Endocrinology 
General Practitioner  
Consultant Rheumatologist (M) 
Consultant Endocrinologist (F) 
Physiotherapy Technician (F) 
Research Coordinator (F) 
Rheumatologist trainee (F) 
General Practitioner trainee (F) 
Junior doctor (M) 
Registrar Rheumatologist (M) 
F1 (F) 
65 minutes 
*Male  
**Female 
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TABLE 4 Baseline case notes review per study site and trial arm (n=80) 
Study Arm Control Intervention Total 
Study Site   1 2 1 2  
Descriptive Variable N (%) 
 
(N=20)
  
(N=20) (N=20) (N=20) (N=80) 
Age Median  
(Range) 
 40-60 
  61-70 
  71-80 
  81-90 
  91-100+ 
83.5 
(58-95) 
2 (10) 
2 (10) 
4 (20) 
8 (40) 
4 (20) 
78.5 
(58-91) 
2 (10) 
3 (15) 
8 (40) 
6 (30) 
1 (5) 
88  
(78-97) 
0 (0) 
0 (0) 
2 (10) 
11 (55) 
7 (35) 
71.5  
(49-90) 
3 (15) 
6 (30) 
6 (30) 
5 (25) 
0 (0) 
81 
(49-97) 
7 (8.75) 
11 (13.75) 
20 (25) 
30 (37.5) 
12 (15) 
Primary diagnosis 
  Cardiology 
  Cancer  
  Acute respiratory 
  Chronic respiratory  
  Stroke 
  Dementia 
  Sepsis 
  Frailty  
  Other 
 
0 (0) 
12 (60) 
5 (25) 
0 (0) 
0 (0) 
0 (0) 
2 (10) 
0 (0) 
0 (0) 
 
0 (0) 
9 (45) 
7 (35) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
4 (20) 
 
4 (20) 
2 (10) 
5 (25) 
0 (0) 
0 (0) 
2 (10) 
1 (5) 
1 (5) 
5 (25) 
 
0 (0) 
6 (30) 
2 (10) 
10 (50) 
1 (5) 
0 (0) 
0 (0) 
0 (0) 
1 (5) 
 
4 (5) 
29 (36.25) 
19 (23.75) 
10 (12.5) 
1 (1.25) 
2 (2.5) 
3 (3.75) 
1 (1.25) 
10 (12.5) 
Clinical uncertainty documented  
  Yes 
  No  
 
18 (90) 
2 (10) 
 
15 (75) 
5 (25) 
 
18 (90) 
2 (10) 
 
12 (60) 
8 (40) 
 
63 (78.75) 
17 (21.25) 
Advance care plan in place 
  Yes 
  No  
 
4a (20) 
16 (80) 
 
8d (40) 
12 (60) 
 
7b (35) 
13 (65) 
 
2c (10) 
18 (90) 
 
21 (26.25) 
59 (73.75) 
Escalation plan documented 
  Yes 
  No  
 
15 (75) 
5 (25) 
 
12 (60) 
8 (40) 
 
18 (90) 
2 (10) 
 
13 (65) 
7 (35) 
 
58 (72.5) 
22 (27.5) 
CPRe status recorded 
  Patient for CPR  
  Patient not for CPR    
  No status recoded  
 
1 (5) 
16 (80) 
3 (15) 
 
0 (0) 
15 (75) 
5 (25) 
 
0 (0) 
20 (100) 
0 (0) 
 
2 (10) 
15 (75) 
3 (15) 
 
3 (3.75) 
66 (82.5) 
11 (13.75) 
Medical plan discussed & agreed with nursing staff 
  Yes 
  No  
 
9 (45) 
11 (55) 
 
15 (75) 
5 (25) 
 
19 (95) 
1 (5) 
 
16 (80) 
4 (20) 
 
59 (73.75) 
21 (26.25) 
Patient ± family discussion  
 Yes 
 No 
 
19 (95) 
1 (5) 
 
14 (70) 
6 (30) 
 
19 (95) 
1 (5) 
 
13 (65) 
7 (35) 
 
65 (81.25) 
15 (18.75) 
Daily follow-up with patient and family 
Yes  
No – should have received  
No – not indicated  
 
19 (95) 
1 (5) 
0 (0) 
 
12 (60) 
7 (35) 
1 (5) 
 
19 (95) 
1 (5) 
0 (0) 
 
12 (60) 
8 (40) 
0 (0) 
 
62 (77.5) 
17 (21.25) 
1 (1.25) 
Assessment of capacity  
Yes  
No – it was not needed 
No – it was needed 
 
11 (55) 
7 (35) 
2 (10) 
 
20(100) 
0 (0) 
 
 
10 (50) 
9 (45) 
1 (5) 
 
7 (35) 
12 (60) 
1 (5) 
 
48 (60) 
28 (35) 
4 (5) 
Preferred place of care 
  Person's own home 
  Hospital 
  Care home 
 
3 (15) 
2 (10) 
0 (0) 
 
7 (35) 
6 (30) 
3 (15) 
 
2 (10) 
2 (10) 
6 (30) 
 
10 (50) 
3 (15) 
3 (15) 
 
22 (27.5) 
13 (16.25) 
12 (15) 
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Study Arm Control Intervention Total 
  Hospice  
  Preference not recorded 
  Other (including undecided patients)  
 
3 (15) 
11 (55) 
1 (5) 
1 (5) 
1 (5) 
2 (10) 
1 (5) 
6 (30) 
3 (15) 
1 (5) 
3 (15) 
0 (0) 
6 (7.5) 
21 (26.25) 
6 (7.5) 
Preferred place of death 
  Person's own home 
  Hospital 
  Care home 
  Hospice  
  Preference not recorded 
  Other (including undecided patients) 
 
 
4 (20) 
2 (10) 
0 (0) 
3 (15) 
11 (55) 
0 (0) 
 
3 (15) 
0 (0) 
4 (20) 
1 (5) 
9 (45) 
3 (15) 
 
1 (5) 
2 (10) 
1 (5) 
2 (10) 
3 (15) 
11 (55) 
 
3 (15) 
0 (0) 
3 (15) 
0 (0) 
12 (60) 
2 (10) 
 
11 (13.75) 
4 (5) 
8 (10) 
6 (7.5) 
35 (43.75) 
16 (20) 
Patient and family wishes  
  Wishes recorded  
  DNAR decision only 
  No wishes recorded  
  Patient declined discussion  
 
5 (25) 
4 (20) 
9 (45) 
1 (5) 
 
12 (60) 
0 (0) 
0 (0) 
8 (40) 
 
16 (80) 
0 (0) 
4 (20) 
0 (0) 
 
10 (50) 
5 (25) 
4 (20) 
1 (5) 
 
43 (53.75) 
9 (11.25) 
17 (21.25) 
10 (12.5) 
Advance care plan in place by condition: site 1 a 3 cancer; 1 acute respiratory; site 2b  1 cancer, 1 acute 
respiratory, and 5 other; site 3c 1 acute respiratory, 1 chronic respiratory; and site 4d 4 cancer, 3 acute 
respiratory, 1 chronic kidney disease, e Cardiopulmonary resuscitation 
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TABLE 5 The classification of the usual care  
 
 
Similarities and embedded practices    
Admission and current care planning 
Initial medical history, assessment processes and care planning consistent across study sites. 87% (n=20) of clinical staff reported completion on patient admission in usual 
care questionnaires; 73.9% (n=17) stated specific time frame (within 6 and 12 hours for control sites 1 and 2, respectively; and ≤24 hours for intervention sites at baseline). 
Presence of electronic scoring systems (e.g. ‘Patient at Risk Score’) mentioned in focus groups and usual care questionnaires at all sites to highlight patients for prioritisation 
during night/weekend shifts. All usual care questionnaire respondents stated medical plans reviewed daily; five stated this occurred rarely at weekends. 
Communication with patient and family 
Case note reviews identified patient and family discussions documented in clinical notes for most patients [range 65% (n=13) at Intervention-Site-2 to 95% (n=19) at 
Intervention-Site-1 (table 4)]. In case note reviews, daily follow-up discussions were present in 60% (n=12) (Intervention-Site-2 and Control-Site-2) to 95% (n=19) (Control-Site-
1 and Intervention-Site-1). 82.6% (n= 19) of usual care questionnaire respondents stated contact would be made with family immediately if patient deteriorated whereas three 
respondents stated informing another team member.  
Escalation decisions 
Case note reviews showed escalation plans, and decisions regarding ‘do not attempt 
resuscitation orders’ (DNAR) to range between 60% (Control-Site-2) to 90% 
(Intervention-Site-1), and 75% (Control-Site-2) to 100% (Intervention-Site-1) of 
patients’ notes, respectively. 56.5% (n=13) of usual care questionnaire respondents 
stated investigations stopped once patient ‘recognised as dying’ and rarely ‘a small 
percentage of patients would have further investigations’. Three respondents 
highlighted escalation decisions relied on recognition of deterioration influenced by 
clinical uncertainty resulting in delays halting further investigations. Consequences of 
not recognising deterioration mentioned during focus group. 
Illustrative Quotes 
You’re told that by the doctor to take some blood when you get to the patient’s arm 
and he has no access and he’s been unconscious. So, you’re trying to get access, but 
the situation is distressing for you, and distressing for the family. (1018, Ward Sister) 
 
Recognising clinical uncertainty 
At baseline, usual care questionnaire respondents were familiar with factors relating to 
situations of clinical uncertainty. Across all sites, common responses referred to “poor 
treatment response” (30%, n=7), followed with “poor scores” (17.4%, n=4), “multi-
morbidities” (13%, n=3) and “frailty” (8.7%, n=2). Documentation of clinical uncertainty 
across sites ranged [60% (n=12, Intervention-Site-2) - 90% (n=18, Control-Site-1)] of 
case note reviews. “Frailty” for recognising clinical uncertainty was mentioned during 
focus group. 
People who are getting frail and deteriorating slowly, it’s a week or two after they 
get there. (2020, Consultant) 
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Emotional support to staff  
All study sites possessed infrastructure for staff emotional support (e.g. electronic 
resources and counselling). However, usual care questionnaire and focus group 
respondents noted they rarely made use of services, turning to each other support.  
 We’ve got a well-being system that can be accessed by any member of staff for 
support. (1021, Research Nurse) 
 I don’t think any of us know about it.  I tend to find that as nurses we provide support 
for one another about how difficult that conversation with that family and that kind 
of thing and we just look after one another, but there’s no formal system that I’m 
aware of. (1022, Staff Nurse)  
Heterogeneity within and across study sites 
Documentation of deterioration and specialist involvement  
Management of clinical uncertainty differed between disciplines/sites. Usual care 
questionnaire identified divergence amongst respondents about whether clinical notes 
of patient would reflect ‘death was likely to occur (during their hospital stay (or shortly 
after)’, and patient/family’s insight (The dying person and their family were aware of 
situation) into their clinical situation. All questionnaire respondents at Control-Site-2 
stated patients’ notes include information about likely death, patient/family insight. At 
other study sites, opposing views indicated heterogeneity amongst healthcare 
professionals’ practices within same ward about documentation practices and 
information provided to patients/families. Nearly all (92%, n=21) respondents across 
sites stated feeling at ease with making palliative care referral, albeit with delays. At 
control site focus groups a continuation of delays in recognising deterioration 
throughout trial present.  
 Not recognising the patient is near ‘end of life’. (Intervention-Site-2004, Staff nurse) 
 Not having a senior clinical decision. (Control-Site-1005, Healthcare assistant) 
 Doctors continuing to treat even though the patient is dying.  (Intervention-Site-2002, 
Ward sister) 
 Uncertainty of doctors. (Intervention-Site-1002, Ward sister) 
 Uncertainty in diagnosis. (Intervention-Site-1006, Physician Associate)  
 You think if these discussions had taken place maybe last week, then we wouldn’t be 
at the point we’re at now. You do ask yourself that quite a lot. (1018, Ward Sister) 
Advance care planning 
Advance care planning documentation practices and supporting patients’ preferences at end of life varied. Case note reviews at baseline identified documentation of advance 
care plans [range 10% (n=2) (Intervention-Site-2) - 40% (n=8) (Control-Site-2)]. 21 of 80 patients had advance care plans documented. Patients’ ‘preferred place of care’ (PPC) 
recorded for 45% (n=9, Control-Site-1), 70% (n=14, Intervention-Site-1), 85% (n=17, Intervention-Site-2) - 95% (n=19, Control-Site-2). 78.2% (n=18) of usual care questionnaire 
respondents state “the whole MDT, patient and family” involved in devising advance care plan. Staff acknowledged on-going process of advance care planning outside hospital 
with GPs. Int1005 referred to advance care planning as “something which needs to be improved on the ward”. Other healthcare professionals from same site highlighted holistic 
approach involving other professionals. Responses about frequency of revising advance care plans with patients/family varied from “not often enough” (Control-Site-2004 – 
Senior Doctor) - “daily” (Control-Site-1005, Control-Site-1004 – Junior Doctors). Triggers included: “end of life”, “deterioration”, “poor prognosis”, “terminal illness”, “futility of 
treatments”, and “frequent admissions” given for advance care plan initiation. Of 23 responses to “What are the triggers for devising or starting the necessary procedures for 
devising an advanced care plan for a patient on this ward?”, only three respondents mentioned patient/family wishes to raise questions about patients’ and families’ roles in 
devising plan.  
Decision-making and communication between ward staff 
Medical teams’ roles in devising medical plan  highlighted by nursing and 
assistant/associate staff across sites in usual care questionnaires. Case note review 
identified agreement with patients’ final medical plan with nursing staff [range 45% 
 I think it’s hard for the front line staff to deal with because we’re the ones who are 
taking the blood from them and we’re putting cannula after cannula after cannula 
and not getting any joy and you know, many problems will come from just simply 
needing to treat but we get the front line. We have to stand and try to take the blood 
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(n=9, Control-Site-1) - 95% (n=19, Intervention-Site-1)]. Usual care questionnaire 
respondents (n=20) reported involvement of multidisciplinary team in making decisions 
about patients’ situations. However, views from focus groups did concord with not. 
Instead, possibility of team members to communicate concerns about patients 
highlighted by control site staff. 
 
in front of the family and all that. It’s different for a doctor to say “Yes, carry on 
treating them.” But they’re not actually the ones in the room delivering the care. I 
don’t know. I think that’s always quite hard on the nursing staff. (1018, Ward Sister) 
 As a junior, you don’t have much say really on dramatically changing management 
plans. Uhmm but anytime I do have I think that when I see a patient, I'm a bit uhmm 
there’s a discrepancy between what I think, how they should be managed then what 
is currently being done, then discuss it with my seniors. (2011, Junior Doctor) 
Competence and confidence in communication  
Although some senior healthcare professionals confident discussing situations of 
clinical uncertainty with patients/families, others stated in usual care questionnaires 
and focus groups lack of proficiency with this aspect of care. Hence, communication 
between healthcare professionals and patients whose situations were clinical 
uncertainty and families varied and depended on individuals’ skills. Impact of individual 
attributes/contextual factors including limited time for communication highlighted 
during focus groups.  
 I find it quite awkward. If you need to break bad news to them then you’re going to, 
it’s going to be emotional for yourself, isn’t it? It’s quite hard to break bad news and 
that’s why people always look to somebody who’s used to doing it a lot. (1018, Ward 
Sister) 
 I find it very time-pressured, very limited time to deal with quite complex issues. 
(2020, Senior Doctor/Clinical Lead) 
Subtle changes in usual care at control sites 
Aspects of usual care provided to patients whose situations were clinically uncertain 
remained unchanged at control sites. However, changes in referral practices to 
palliative care team and improved confidence communicating with patients/families 
observed at Control-Site-2. A senior doctor (baseline usual care questionnaire not 
comfortable making palliative care referrals for non-cancer patients], stated during 
focus group, at end of trial her conduct improved, a view shared by colleagues. 
Although no changes during trial recorded at Control-Site-1, plans for hospital-wide 
implementation of similar intervention mentioned during focus groups. 
 It helps us I think reflect a bit more on non-cancer patients…To make the team more 
aware that this may be a group that we previously missed in terms of getting them 
identified and also support for end of life. (2021, Senior Doctor/Clinical Lead) 
 Generally, escalation plan. Like, where they… if anything was to happen at that 
admission, how far would that patient and family want?  What are their wishes? 
Would they want to be on ITU, tubed and that sort of stuff…? They sound quite 
similar; I’m thinking relating to AMBER. (1018, Ward Sister) 
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